Contract HHSD200201458151C
Glaxosmithkline, Llc · Department Of Health And Human Services · September 30, 2021
Glaxosmithkline, Llc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 30, 2021 for $688.41 million (current value) of work in pharmaceutical preparation manufacturing. Performance is in Durham, NC. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $688.41 million.
Contract details
- PIID
- HHSD200201458151C
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Durham, NC
- First action
- September 30, 2021
Description
VACCINE FOR CHILDREN (VFC) 2014
Modification timeline
-
September 30, 2021Mod 17 · Other Administrative Action$602.05M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD200201458151C?
Contract HHSD200201458151C is a federal contract awarded to Glaxosmithkline, Llc by Department Of Health And Human Services on September 30, 2021 for $688.41 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSD200201458151C?
Glaxosmithkline, Llc won contract HHSD200201458151C from Department Of Health And Human Services.
How much is contract HHSD200201458151C worth?
Contract HHSD200201458151C has obligated $0 to date but carries a potential ceiling of $688.41 million if fully funded and all options are exercised.